These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25002730)

  • 1. Combining cetuximab with chemoradiotherapy in locally advanced head and neck squamous cell carcinoma: is more better?
    Psyrri A; Dafni U
    J Clin Oncol; 2014 Sep; 32(27):2929-31. PubMed ID: 25002730
    [No Abstract]   [Full Text] [Related]  

  • 2. Cisplatin Versus Cetuximab With Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
    Husain ZA; Burtness BA; Decker RH
    J Clin Oncol; 2016 Feb; 34(5):396-8. PubMed ID: 26644528
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy in locally advanced head and neck squamous cell carcinoma.
    Gyawali B; Shimokata T; Honda K; Ando Y
    Cancer Treat Rev; 2016 Mar; 44():10-6. PubMed ID: 26924194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma.
    Nishimura G; Taguchi T; Takahashi M; Shiono O; Komatsu M; Sano D; Yabuki K; Arai Y; Takahashi H; Hata M; Oridate N
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1315-9. PubMed ID: 27154176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy: Cetuximab or cisplatin in HNSCC?
    Hutchinson L
    Nat Rev Clin Oncol; 2016 Feb; 13(2):66. PubMed ID: 26718111
    [No Abstract]   [Full Text] [Related]  

  • 6. RTOG 0522: huge Investment in patients and resources and no benefit with addition of cetuximab to radiotherapy--why did this occur?
    Adkins D; Ley J; Wildes TM; Michel L
    J Clin Oncol; 2015 Apr; 33(10):1223-4. PubMed ID: 25713440
    [No Abstract]   [Full Text] [Related]  

  • 7. The Italian Collaborative Group sets a standard for the treatment of locally advanced head and neck cancer.
    Misiukiewicz K; Gupta V; Posner M
    Ann Oncol; 2017 Sep; 28(9):2051-2054. PubMed ID: 28911089
    [No Abstract]   [Full Text] [Related]  

  • 8. Concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck.
    Komatsu M; Shiono O; Taguchi T; Sakuma Y; Nishimura G; Sano D; Sakuma N; Yabuki K; Arai Y; Takahashi M; Isitoya J; Oridate N
    Jpn J Clin Oncol; 2014 May; 44(5):416-21. PubMed ID: 24688084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Planned neck dissection in the treatment of locally advanced head and neck squamous cell carcinoma].
    Jiang L; Lou JL; Wang KJ; Fang MY; Fu ZF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):92-96. PubMed ID: 29429177
    [No Abstract]   [Full Text] [Related]  

  • 10. Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.
    Giralt J; Trigo J; Nuyts S; Ozsahin M; Skladowski K; Hatoum G; Daisne JF; Yunes Ancona AC; Cmelak A; Mesía R; Zhang A; Oliner KS; VanderWalde A
    Lancet Oncol; 2015 Feb; 16(2):221-32. PubMed ID: 25596659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a cisplatin and paclitaxel induction regimen followed by chemoradiotherapy for patients with locally advanced head and neck squamous cell carcinoma.
    de Souza Viana L; de Aguiar Silva FC; Andrade Dos Anjos Jacome A; Calheiros Campelo Maia D; Duarte de Mattos M; Arthur Jacinto A; Elias Mamere A; Boldrini Junior D; de Castro Capuzzo R; Roberto Santos C; Lopes Carvalho A
    Head Neck; 2016 Apr; 38 Suppl 1():E970-80. PubMed ID: 26031625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas.
    Prestwich RJ; Öksüz DÇ; Dyker K; Coyle C; Şen M
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e237-43. PubMed ID: 21620580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reply to D. Adkins et al.
    Psyrri A; Economopoulou P; Dafni U
    J Clin Oncol; 2015 Apr; 33(10):1225-6. PubMed ID: 25713435
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to D. Adkins et al.
    Axelrod RS; Sherman E; Garden A; Nguyen-Tan PF; Trotti A; Yom SS; Zhang Q
    J Clin Oncol; 2015 Apr; 33(10):1224-5. PubMed ID: 25713438
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial.
    Mesía R; Henke M; Fortin A; Minn H; Yunes Ancona AC; Cmelak A; Markowitz AB; Hotte SJ; Singh S; Chan AT; Merlano MC; Skladowski K; Zhang A; Oliner KS; VanderWalde A; Giralt J
    Lancet Oncol; 2015 Feb; 16(2):208-20. PubMed ID: 25596660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Panitumumab for locally advanced head and neck squamous-cell carcinoma.
    Ishiki H; Iwase S; Shimada N; Chiba T; Imai K
    Lancet Oncol; 2015 Apr; 16(4):e156. PubMed ID: 25846092
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase 2 Study of Docetaxel, Cisplatin, and Concurrent Radiation for Technically Resectable Stage III-IV Squamous Cell Carcinoma of the Head and Neck: In Regard to Inohara et al.
    Puthiyottil SS; Bhattacharyya T; Purushothaman K; Muttath G
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):469-70. PubMed ID: 26383688
    [No Abstract]   [Full Text] [Related]  

  • 18. Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial.
    Magrini SM; Buglione M; Corvò R; Pirtoli L; Paiar F; Ponticelli P; Petrucci A; Bacigalupo A; Crociani M; Lastrucci L; Vecchio S; Bonomo P; Pasinetti N; Triggiani L; Cavagnini R; Costa L; Tonoli S; Maddalo M; Grisanti S
    J Clin Oncol; 2016 Feb; 34(5):427-35. PubMed ID: 26644536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Reply to Puthiyottil et al.
    Inohara H
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):470-1. PubMed ID: 26383689
    [No Abstract]   [Full Text] [Related]  

  • 20. Neoadjuvant TPF in locally advanced head and neck cancer can be followed by radiotherapy combined with cisplatin or cetuximab: a study of 157 patients.
    Fayette J; Bonnin N; Ferlay C; Lallemant B; Ramade A; Favrel V; Zrounba P; Chabaud S; Pommier P; Poupart M; Céruse P
    Anticancer Drugs; 2013 Jul; 24(6):623-9. PubMed ID: 23542750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.